Entering text into the input field will update the search result below

Eli Lilly's Jardiance provides benefit for acute heart failure patients

Mar. 01, 2022 12:07 PM ETEli Lilly and Company (LLY)By: Jonathan Block, SA News Editor

Human heart with blocked arteries

Rasi Bhadramani/iStock via Getty Images

  • Eli Lilly's (LLY -1.7%) type 2 diabetes medication Jardiance (empagliflozin) provides clinical benefit to heart failure patients in terms of all-cause mortality, frequency of heart failure events, and time to first heart failure event

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About LLY

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Eli Lilly and Company
Johnson & Johnson
Merck & Co., Inc.
Roche Holding AG
AstraZeneca PLC
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.